Veracyte, Inc.
VCYT
$31.55
$1.123.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.14M | -9.27M | -54.04M | -68.18M | -74.40M |
| Total Depreciation and Amortization | 23.46M | 23.54M | 24.99M | 26.11M | 27.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.82M | 67.54M | 96.54M | 96.03M | 95.60M |
| Change in Net Operating Assets | -21.32M | -15.69M | -17.15M | -16.53M | -4.16M |
| Cash from Operations | 75.10M | 66.12M | 50.33M | 37.43M | 44.22M |
| Capital Expenditure | -11.29M | -9.64M | -10.20M | -11.10M | -9.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.01M | 5.01M | 5.01M | 5.01M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00M | 0.00 | 0.00 | 0.00 | 25.07M |
| Cash from Investing | -56.28M | -4.63M | -5.19M | -6.09M | 15.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.99M | 18.50M | 8.59M | 8.58M | 9.58M |
| Repurchase of Common Stock | -10.59M | -8.44M | -8.71M | -8.30M | -6.74M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.50M | -- | -- | -- | -- |
| Cash from Financing | 4.90M | 10.06M | -120.00K | 288.00K | 2.84M |
| Foreign Exchange rate Adjustments | -424.00K | 274.00K | -49.00K | 5.00K | 163.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.30M | 71.83M | 44.97M | 31.63M | 62.33M |
